On December 22 to 24, 2013, the provincial Food & Drug Administration GMP certification inspection team inspected Daphne tablets, granules, powder, capsules, BPC, TCM pretreatment & extraction drugs. They also inspected Daphne's environment, herbal packages storeroom, cool storeroom, finished product storeroom, auxiliary material storeroom, packaging material storeroom, sample room, water production system, air conditioning & purifying system, compressed air system, quality control room and relevant procedures & records. Through document examination, site checking, site questioning and record checkout, they completed inspection of 12 items one by one, including Daphne's QA system, organization & employees, production premises & equipment, materials & products, production management, quality control & assurance, sanitation, verification and validation, documents, product launch & recall, self-check, and outsourcing of manufacturing and test. Through 3-day work, the inspection team takes the view that Daphne has a perfect organization, meeting the specified requirements; layout of the production premises is well arranged; production & testing equipment is well provided, meeting the need of production and testing; main equipment is verified; the production management is reasonable; the material & product management is virtually normalized; the production & quality management documents are complete; and the persons are trained and certified. No critical or major defect was identified in site inspection, meeting the requirements of Drug Production GMP (2010 Revision).